Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. (ARQT) is a publicly traded company in the Unknown sector. Across all available filings, 30 corporate insiders have executed 520 transactions totaling $120.3M, demonstrating a bullish sentiment with $22.2M in net insider flow. The most recent transaction on Feb 4, 2026 involved a sale of 9,794 shares valued at $252.7K.
ARQT Insider Activity Summary
Who Is Buying ARQT Stock?
No significant insider buying has been recorded for ARQT in the recent period.
Who Is Selling ARQT Stock?
No significant insider selling has been recorded for ARQT in the recent period.
Is Arcutis Biotherapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ARQT is bullish with an Insider Alignment Score of 59/100 and a net flow of $22.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ARQT Frequently Asked Questions
Understanding ARQT Insider Activity
Insider trading at Arcutis Biotherapeutics, Inc. (ARQT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 30 insiders are actively trading ARQT stock, having executed 520 transactions in the past 90 days. The most active insider is Capital Llc Orbimed (Executive), who has made 11 transactions totaling $27.7M.
Related Tools
Track Arcutis Biotherapeutics, Inc. Insider Activity
Get notified when executives and directors at ARQT file new Form 4 transactions